Work

Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy

Year: 2026
Type: article
Abstract: BACKGROUND: Amoxicillin (AX) is frequently implicated in immediate IgE-mediated allergic reactions. Diagnosis is challenging, highlighting the need for new approaches enhancing in vitro sensitivity and specificity. Engineered nanostructures can mimic immunological recognition of hapten-carrier conjugates, offering a strategy to improve diagnostic accuracy. METHODS: Dendrimeric Antigens (DeAns), with controlled size (1st-5th generation) and multivalent AX determinants (8-128 units, respectively), were synthesized for in vitro immunological evaluation. In vitro IgE recognition was studied by competitive radio-immunoassay. Allergenic activity was evaluated in mouse bone marrow-derived mast cells (MC) sensitized with mouse anti-AX IgE monoclonal antibody and humanized RBL-2H3 (huRBL-2H3) and LUVA cells sensitized with sera from β-lactam-allergic subjects and tolerant controls, measuring degranulation in response to DeAns stimulation. RESULTS: Five different DeAns were obtained as pure compounds. All DeAns were recognized by AX-sIgE. A clear size-dependent activation pattern was observed in the three cell models: lower-generation (1st-2nd) DeAns failed to induce degranulation, whereas DeAns of bigger size (3rd-5th generation) triggered significant, dose-dependent activation. Notably, no activation was observed in tolerants and unsensitized cells or with blank dendrimers. In patient-sera assays, the passive MC activation test (pMAT) with DeAns provided complete diagnostic discrimination, with activation restricted to AX-allergic patients. CONCLUSIONS: DeAns are effective platforms for investigating effector cell activation in AX allergy. By fine-tuning structural attributes-size and multivalence-we reveal the promising utility of DeAns in pMAT that leverage commercial cell lines and patient sera. This approach could address key limitations of β-lactam allergy diagnostics, enabling more reliable and standardized in vitro testing.
Source: Allergy
Language: English
Subfield: Pharmacology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $5,300
Awards: G1105844351, G1175115578, G1855990336, G1962745078, G201340151, G2262748287, G2309174360, G2601397997, G2660406951, G2672435700, Aplicación de nanoarquitecturas sintéticas al estudio de los mecanismos de activación del basófilo y al diagnóstico en reacciones alérgicas a amoxicilina, G300979063, G3117242519, Nuevas aproximaciones aplicadas al diagnóstico de alergia a fármacos: Desarrollo de nanoestructuras que incorporan ligando TLR y determinantes antigénicos de antibióticos betalactámicos., G3480869486, G3681454997, Nanoarquitecturas altamente eficientes para un entrecruzamiento eficaz de la IgE en mastocitos y basófilos. Aplicación al diagnóstico de reacciones alérgicas a amoxicilina y ácido clavulánico., G4004671811, G4042783231, G425668148, G430777504, G4833715428, Optimización diagnóstica en alergia a betalactámicos: de la estandarización y racionalización de las pruebas in vivo, al desarrollo de test in vitro innovadores basados en nanotecnología y metabolómica., G491712853, Nanomedicine Doctoral Programme, G4937468798, G5080475149, G5167452342, G5195188938, G5421974903, G5781591375, G5997385541, G683931746, G7084143925, Nanodiagnóstico para la hipersensibilidad a betalactámicos, G7805626310, G7834924252, G7863371703, G7892477181, G8347645112, G8497050386, G8696694383, G871842226, G8777962859, G8824911526, En busca del diagnóstico correcto de la alergia a betalactámicos: desde la validación de una herramienta de estratificación del riesgo a un endotipado preciso, G8920660035, G8988427660, G99296377
OpenAlex ID: W7128607652
FWCI:
Cites: 55
Cited by:
Related to: